Apellis Pharmaceuticals, Inc. - Common Stock (APLS)
29.01
-1.38 (-4.54%)
Apellis Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapies for the treatment of serious diseases through its expertise in complement biology
The company works on advancing its proprietary drug candidates designed to modulate the immune system, with particular attention to rare and complex conditions that currently have limited treatment options. By harnessing advanced science and technology, Apellis aims to improve patient outcomes and address unmet medical needs in various therapeutic areas, including hematology and ophthalmology.
Frequently Asked Questions
Is Apellis Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Apellis Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Apellis Pharmaceuticals, Inc. - Common Stock trade on?
Apellis Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Apellis Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Apellis Pharmaceuticals, Inc. - Common Stock is APLS on the Nasdaq Stock Market
What is the current price of Apellis Pharmaceuticals, Inc. - Common Stock?
The current price of Apellis Pharmaceuticals, Inc. - Common Stock is 29.01
When was Apellis Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Apellis Pharmaceuticals, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Apellis Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Apellis Pharmaceuticals, Inc. - Common Stock is 3.38B
How many shares of Apellis Pharmaceuticals, Inc. - Common Stock are outstanding?
Apellis Pharmaceuticals, Inc. - Common Stock has 116.46M shares outstanding.